Positive news buoys a beleaguered field, but treatment benefits may fade. Eric Pierce (Mass. Eye & Ear) and Luk Vandenberghe (Mass. Eye & Ear) are quoted.
There is a new price surge in the pharmaceutical industry—for a limited number of government-issued vouchers that drug makers including, AbbVie Inc. and Sanofi SA, are buying to speed products to market. Aaron Kesselheim (Brigham and Women’s) is quoted.
The idea of using a patient’s biological information to improve and tailor treatment has gone from niche to mainstream. But as the practice gains popularity, experts point out a number of issues that the medical community has yet to tackle. Barrett Rollins (Dana-Farber) is quoted.
One of the most respected and influential groups in the continuing breast-cancer screening debate said on Tuesday that women should begin mammograms later and have them less frequently than it had long advocated. Nancy Keating (HMS) co-authored an editorial accompanying the new guidelines.
As hospitals have acquired more doctor practices, prices for outpatient medical services have gone up, according to a new study that will fuel debate over the impact of the merger boom sweeping through health care. J. Michael McWilliams (HMS) is author of the study.
Frequent face time trumps phone calls or e-mail in helping to ward off depression in older adults, researchers found. Nancy Donovan (Brigham and Women’s) is quoted.
